financetom
Business
financetom
/
Business
/
Reese Consumer Health Acquires Topical Pain Relief Brand Australian Dream
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Reese Consumer Health Acquires Topical Pain Relief Brand Australian Dream
Aug 13, 2026 6:02 AM

CLEVELAND, Aug. 13, 2026 (GLOBE NEWSWIRE) -- Reese Consumer Health today announced the acquisition of Australian Dream, a nationally recognized consumer health brand specializing in topical pain relief for arthritis, muscle, and joint discomfort.

The acquisition strengthens Reese’s presence in the OTC pain relief category and adds an established brand with a loyal consumer following to its growing health and wellness portfolio. Reese plans to use its category expertise, consumer insights, and longstanding retail relationships to expand Australian Dream’s reach across retail, e-commerce and direct-to-consumer channels.

“Australian Dream brings strong brand heritage, a meaningful point of difference, and a loyal consumer base—exactly the kind of foundation we believe can support significant growth,” said Jeff Reese, President of Reese Consumer Health. “By combining Australian Dream’s established consumer base with Reese’s capabilities in innovation, marketing, and retail execution, we see a significant opportunity for continued growth.”

The acquisition also expands the ways Reese can engage directly with consumers and learn from how they discover, purchase, and use health and wellness products.

“Adding Australian Dream strengthens not only our brand portfolio, but our ability to serve both consumers and our retail partners,” said Joseph Juliano, Vice President of Sales/Marketing/New Business Development. “More products and more touchpoints across both retail and e-commerce give us a better insight into what consumers are looking and how shopping behavior is changing. We can bring those insights back to our retail partners to identify opportunities, develop the right products and get them to market faster.”

The announcement comes as Reese prepares to meet with retailers and industry partners at the NACDS Total Store Expo in Boston this weekend (Booth #1438Q). The company continues to invest in expanding its consumer reach and capabilities, including its first entry into international markets last fall and a new Cleveland facility planned for 2027.

About Reese Consumer Health

Founded in 1907 and headquartered in Cleveland, Ohio, Reese Consumer Health Corporation is a privately held manufacturer of branded and private label products selling to national and regional chains, food and grocery, drug wholesalers, co-ops, and independent pharmacies.

Media Contact:

Andrea LePain

[email protected]

617-894-1153

Photos accompanying this announcement are available at:

https://www.globenewswire.com/NewsRoom/AttachmentNg/e159d145-2c89-4b98-a197-37782645896d

https://www.globenewswire.com/NewsRoom/AttachmentNg/b5b0472f-e140-4b88-9053-28705bf951f9

https://www.globenewswire.com/NewsRoom/AttachmentNg/a4253281-a727-46ae-8b0f-580f1b3264fc

https://www.globenewswire.com/NewsRoom/AttachmentNg/bdef110a-742f-4b74-ad73-4a08f54612ec

Image: https://www.globenewswire.com/newsroom/ti?nf=OTgwOTUxMyM3Nzc0OTcwIzUwMDE2NjQ3NA==

Image: https://ml.globenewswire.com/media/NTg5MmNhOGUtMzczMS00MGQ3LWFhYTYtOGE2MmExNWM4YzBkLTUwMDE2NjQ3NC0yMDI2LTA4LTEzLWVu/tiny/Reese-Consumer-Health.png Image: Primary Logo

Australian Dream Back Pain and Arthritis Pain Relief Cream

Image: https://ml.globenewswire.com/media/e159d145-2c89-4b98-a197-37782645896d/medium/australian-dream-back-pain-and-arthritis-pain-relief-cream.png

Australian Dream Back Pain and Arthritis Pain Relief Cream
Australian Dream Arthritis Pain Relief Cream

Image: https://ml.globenewswire.com/media/b5b0472f-e140-4b88-9053-28705bf951f9/medium/australian-dream-arthritis-pain-relief-cream.png

Australian Dream Arthritis Pain Relief Cream
Australian Dream Logo

Image: https://ml.globenewswire.com/media/a4253281-a727-46ae-8b0f-580f1b3264fc/medium/australian-dream-logo.jpg

Australian Dream Logo
Australian Dream Back Pain Relief Cream

Image: https://ml.globenewswire.com/media/bdef110a-742f-4b74-ad73-4a08f54612ec/medium/australian-dream-back-pain-relief-cream.png

Australian Dream Back Pain Relief Cream

Source: Reese Consumer Health

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Velan Q1 sales rise 18.6%, raises dividend
Velan Q1 sales rise 18.6%, raises dividend
Jul 10, 2025
Overview * Velan's ( VLNSF ) fiscal Q1 sales rise 18.6% to $72.2 mln, boosting gross profit margin * Reports net income from continuing operations of $17.8 mln compared to loss of $2.2 mln a year earlier * Increases quarterly dividend to C$0.10 per share from C$0.03 Outlook * Velan ( VLNSF ) expects to deliver solid performance despite tariff...
Roku Insider Sold Shares Worth $2,241,032, According to a Recent SEC Filing
Roku Insider Sold Shares Worth $2,241,032, According to a Recent SEC Filing
Jul 10, 2025
06:00 PM EDT, 07/10/2025 (MT Newswires) -- Anthony J. Wood, 10% Owner, Director, CEO and Chairman of Board of Directors, on July 10, 2025, sold 25,000 shares in Roku ( ROKU ) for $2,241,032. Following the Form 4 filing with the SEC, Wood has control over a total of 503,034 Class A common shares of the company, with 11,953 shares...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Delaware Supreme Court sides with Zantac drugmakers over cancer evidence
Delaware Supreme Court sides with Zantac drugmakers over cancer evidence
Jul 10, 2025
* Patients allege that heartburn drug caused their cancer * Court says expert opinions not backed by reliable science * FDA asked in 2020 that Zantac be pulled from market * Lawyer for patients had no immediate comment (Adds details from decision, attempts to obtain comment, case citation, byline) By Jonathan Stempel July 10 (Reuters) - Delaware's highest court ruled...
Copyright 2023-2026 - www.financetom.com All Rights Reserved